Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 7
Original Research
Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,678 | Dovepress* | 11,478+ | 2,362 | 13,840 | |
| PubMed Central* | 2,200 | 567 | 2,767 | ||
| Totals | 13,678 | 2,929 | 16,607 | ||
|
*Since 9 August 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar